The February 2011 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper:
Volume 17, Issue 1
Editorial
| Applying design thinking to biotechnology | |
| Yali Friedman |
Commentary
| Building biotechnology by design: An entrepreneur’s perspective | |
| Arthur A Boni |
| Building biotechnology by design: Role of biotechnology in development | |
| Patrick Nef |
Articles
| Pricing biologics: Issues, strategic priorities and a conceptual model | |
| Sanjay K Rao |
| Revitalizing portfolio decision-making at Merck Serono S.A. – Geneva | |
| Vincent Aurentz, Bernhard Kirschbaum, Markus Thunecke |
| Global consensus – Need of the hour for genetically modified organisms (GMO) labeling | |
| Jagadeesan Premanandh |
| Beyond investment: Advancing the biotechnology sector in the countries of the Gulf Cooperation Council (GCC) | |
| Leonard Lerer, Brett Bowman |
Case Study
| Repurposing of the epidermal growth factor | |
| Ernesto L Mola, José A Buxadó, Luis Herrera |
| Biotechnology commercialization: A case study from Central and Eastern Europe | |
| Dana Ukropcova, Ernest Sturdik |
| The developments in the business models of biotechnology in the Central and Eastern European countries: The example of Estonia | |
| Margit Suurna |
Legal and Regulatory Updates
| EU Legal and Regulatory Update | |
| Gerry Kamstra |